title: Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
authors: Raffaele
authors: R
authors: Bruno
authors: Paolo
authors: P
authors: Sacchi
authors: Gaetano
authors: G
authors: Filice
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D006801:Humans; D017093:Liver Failure / Q000188:drug therapy* / Q000473:pathology*; D016031:Liver Transplantation; D063065:Organophosphonates / Q000627:therapeutic use*; D012720:Severity of Illness Index; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine